Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Assets (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Assets for 16 consecutive years, with $106.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets rose 7.52% to $106.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $106.3 million, a 7.52% increase, with the full-year FY2024 number at $93.8 million, up 1.32% from a year prior.
  • Assets was $106.3 million for Q3 2025 at Xtant Medical Holdings, up from $103.5 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $106.3 million in Q3 2025 to a low of $52.7 million in Q2 2022.
  • A 5-year average of $76.4 million and a median of $65.2 million in 2023 define the central range for Assets.
  • Peak YoY movement for Assets: fell 11.67% in 2022, then surged 64.15% in 2023.
  • Xtant Medical Holdings' Assets stood at $54.7 million in 2021, then rose by 10.12% to $60.2 million in 2022, then surged by 53.77% to $92.6 million in 2023, then rose by 1.32% to $93.8 million in 2024, then increased by 13.3% to $106.3 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Assets are $106.3 million (Q3 2025), $103.5 million (Q2 2025), and $95.8 million (Q1 2025).